# Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

> **NCT00441740** · PHASE3 · COMPLETED · sponsor: **Hellenic Oncology Research Group** · enrollment: 419 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Vinorelbine
- **DRUG:** Gemcitabine
- **DRUG:** Docetaxel
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00441740
- **Lead sponsor:** Hellenic Oncology Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2008-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441740, "Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00441740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*